California Jury Says J&J (JNJ) Defectively Designed ASR Hip Device
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/13/2026
- S&P 500, Nasdaq decline as Iran tensions jolt sentiment; chip stocks fall
- SK Hynix’s record plunge drags down global chip stocks
- Oil gains over 4% as Trump says US reinstating Iran naval blockade
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Goldman Sachs Upgrades NIO (NIO) to Buy
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- S&P 500, Nasdaq decline as Iran tensions jolt sentiment; chip stocks fall
- Japan has no plans to overhaul pension funds' asset allocation, sources say
Johnson & Johnson (JNJ) Hip Implant Verdict to be Readt at 12:30pm ET
March 8, 2013 12:23 PM ESTJohnson & Johnson (NYSE: JNJ) hip implant jury verdict to be read at 9:30am in Los Angeles (PST), or 12:30pm EST.
Johnson & Johnson was accused of selling a defective hip implant.
Shares are up 0.4 percent Friday.... More
